CD34 and Duchenne muscular dystrophy: We stratified the DMD patients into two groups according to the results obtained from linear regression analysis of age and levels of CD133+CXCR4+CD34- cells, and then performed a detailed follow-up of 12 or 24 months on a subgroup of 19 DMD patients.